Skip to content

FENNEC PHARMACEUTICALS INC. (FENC) Insider Trading -- Recent Executive & Director Transactions

13 insiders reported 159 Form 4 transactions for FENNEC PHARMACEUTICALS INC. (FENC) over the past 18 months (most recent 2026-10-01). Recent activity: Andrade Robert (CHIEF FINANCIAL OFFICER) Buy 1,703 shares, Hackman Jeffrey S. (Chief Executive Officer) Buy 1,159 shares, Evans Terry L (Chief Commercial Officer) Buy 168 shares, Sayad Pierre Sargis (Chief Medical Officer) Buy 168 shares, Cioffi Christiana Marie (Chief Strategy Officer) Buy 156 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-10-01Andrade RobertCHIEF FINANCIAL OFFICERBuy1,703$0
2026-10-01Hackman Jeffrey S.Chief Executive OfficerBuy1,159$0
2026-10-01Evans Terry LChief Commercial OfficerBuy168$0
2026-10-01Sayad Pierre SargisChief Medical OfficerBuy168$0
2026-10-01Cioffi Christiana MarieChief Strategy OfficerBuy156$0
2026-09-16Brughera Marco MariaDirectorBuy15,545$32,800
2026-09-16Brughera Marco MariaDirectorSell15,545$159,958
2026-09-01Raykov RostyInsiderBuy2,778$0
2026-09-01Raykov RostyInsiderSell10,000$121,100
2026-08-31Andrade RobertCHIEF FINANCIAL OFFICERBuy1,703$0
2026-08-31Hackman Jeffrey S.Chief Executive OfficerBuy1,159$0
2026-08-31Evans Terry LChief Commercial OfficerBuy168$0
2026-08-31Cioffi Christiana MarieChief Strategy OfficerBuy156$0
2026-08-31Sayad Pierre SargisChief Medical OfficerSell12,000$146,160
2026-08-31Sayad Pierre SargisChief Medical OfficerBuy168$0
2026-08-28Andrade RobertCHIEF FINANCIAL OFFICERSell75,000$883,500
2026-08-28Andrade RobertCHIEF FINANCIAL OFFICERBuy21,928$111,833
2026-08-04Raykov RostyInsiderSell10,000$95,800
2026-08-03Andrade RobertCHIEF FINANCIAL OFFICERBuy1,703$0
2026-08-03Raykov RostyInsiderBuy2,778$0
2026-08-03Hackman Jeffrey S.Chief Executive OfficerBuy1,159$0
2026-08-03Evans Terry LChief Commercial OfficerBuy168$0
2026-08-03Sayad Pierre SargisChief Medical OfficerBuy168$0
2026-08-03Cioffi Christiana MarieChief Strategy OfficerBuy156$0
2026-07-02Raykov RostyInsiderBuy2,778$0

Source: SEC Form 4 filings · as of 2026-10-01